Cefdinir
Average across 16 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Proficient Rx LP | unknown | 8 | SUPPLYING |
| A-S Medication Solutions | unknown | 7 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | unknown | 6 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 4 | SUPPLYING |
| Lupin Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 4 | SUPPLYING |
| Direct_Rx | unknown | 4 | SUPPLYING |
| Preferred Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 4 | SUPPLYING |
| Asclemed USA, Inc. | unknown | 4 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Defective container: lack of seal integrity. — Recalling firm: Lupin Pharmaceuticals Inc. — USA Nationwide
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle. — Recalling firm: Lupin Pharmaceuticals Inc. — USA nationwide
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle. — Recalling firm: Lupin Pharmaceuticals Inc. — USA nationwide
Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples. — Recalling firm: Lupin Pharmaceuticals Inc. — U.S.A. Nationwide
Presence of Foreign substance: identified as a dead ant. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to major distributors/wholesalers throughout the United States.
Presence of Foreign substance: identified as a dead ant. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to major distributors/wholesalers throughout the United States.
Complaint received of metal piece identified in the product bottle prior to the reconstitution. — Recalling firm: Lupin Pharmaceuticals Inc. — Distributed Nationwide in the USA
CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States
CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States
Superpotent Drug — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide
Pill